NPTX2 and Cognitive impairment: Therefore, when the pathophysiological role of NPTX2 levels in cognitive impairment in patients with diabetes is fully proven, the current biomarkers may guide both rapid and early diagnosis and the development of an effective treatment modality via NTPX2.